AXQ Capital
LKFT icon

AXQ Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

AXQ Capital’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,777
Closed -$203K – 1116
2026
Q1 		$203K Buy
+6,777
New +$224K 0.03% 742
2023
Q2 		– Sell
-5,389
Closed -$208K – 407
2023
Q1 		$208K Buy
+5,389
New +$222K 0.08% 399

Other funds holding LKFT

Gilead Sciences
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Madison Avenue Partners
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Prosight Management
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DME Capital Management
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

AXQ Capital's LKFT Position: Q2 2026 in Review

AXQ Capital sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 6,777 shares — an estimated $203K sold.

AXQ Capital first reported a position in LKFT in Q1 2023 and held it in 2 quarters. The position peaked at $208K in Q1 2023. 78 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • AXQ Capital reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • AXQ Capital sold 6,777 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $203K.
  • AXQ Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2023 and held it in 2 quarters.
  • AXQ Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $208K in Q1 2023.
  • 78 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.